does glp 1 increase risk of cancer GLP-1RA and thyroid cancer: New study suggests detection bias, not causation GLP-1s may reduce cancer risk

Commercially insured patients show a similar trend: 36% who began GLP-1 therapy in 2024 did not add another drug within a year, a significant rise from 13% in 2020

(Hims & Hers, NYSE: HIMS), the leading health and wellness platform, today shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need

What if you want to stop taking a GLP-1

Work schedules, stress, sleep, travel and major life changes all influence eating habits and weight over time